181 related articles for article (PubMed ID: 10446394)
1. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
Davies GF; Khandelwal RL; Roesler WJ
Biochim Biophys Acta; 1999 Aug; 1451(1):122-31. PubMed ID: 10446394
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism.
Davies GF; Khandelwal RL; Wu L; Juurlink BH; Roesler WJ
Biochem Pharmacol; 2001 Oct; 62(8):1071-9. PubMed ID: 11597575
[TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
Aoki K; Kikuchi T; Mukasa K; Ito S; Nakajima A; Satoh S; Okamura A; Sekihara H
Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
[TBL] [Abstract][Full Text] [Related]
4. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
Russell JC; Ravel D; Pégorier JP; Delrat P; Jochemsen R; O'Brien SF; Kelly SE; Davidge ST; Brindley DN
J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115
[TBL] [Abstract][Full Text] [Related]
5. Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.
Raman P; Foster SE; Stokes MC; Strenge JK; Judd RL
Life Sci; 1998; 62(8):PL89-94. PubMed ID: 9489515
[TBL] [Abstract][Full Text] [Related]
6. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
Raman P; Judd RL
Eur J Pharmacol; 2000 Dec; 409(1):19-29. PubMed ID: 11099696
[TBL] [Abstract][Full Text] [Related]
7. [Effect of metformin on gene expression of phosphoenolpyruvate carboxykinase].
Yuan L; Ziegler R; Hamann A
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):663-6. PubMed ID: 12485530
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
9. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
Fulgencio JP; Kohl C; Girard J; Pégorier JP
Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes.
Yuan L; Ziegler R; Hamann A
Chin Med J (Engl); 2002 Dec; 115(12):1843-8. PubMed ID: 12622936
[TBL] [Abstract][Full Text] [Related]
12. [Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids].
Barthel A; Scherbaum WA; Bornstein SR
Med Klin (Munich); 2003 Apr; 98(5):283-6. PubMed ID: 12721674
[TBL] [Abstract][Full Text] [Related]
13. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
14. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone induces expression of PPARgamma in liver.
Davies GF; Khandelwal RL; Roesler WJ
Mol Cell Biol Res Commun; 1999; 2(3):202-8. PubMed ID: 10662598
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats.
Chen CC; Wang HJ; Shih HC; Sheen LY; Chang CT; Chen RH; Wang TY
J Formos Med Assoc; 2001 Mar; 100(3):176-80. PubMed ID: 11393112
[TBL] [Abstract][Full Text] [Related]
17. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
18. Effects of oolong tea on gene expression of gluconeogenic enzymes in the mouse liver and in rat hepatoma H4IIE cells.
Yasui K; Miyoshi N; Tababe H; Ishigami Y; Fukutomi R; Imai S; Isemura M
J Med Food; 2011 Sep; 14(9):930-8. PubMed ID: 21812644
[TBL] [Abstract][Full Text] [Related]
19. UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats.
Oberkofler H; Neschen S; Esterbauer H; Waldhäusl W; Patsch W; Fürnsinn C
Biochim Biophys Acta; 2000 Dec; 1517(1):113-8. PubMed ID: 11118623
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
